Equities research analysts expect that Motus GI Holdings, Inc. (NASDAQ:MOTS) will report earnings per share of ($0.10) for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Motus GI’s earnings. The highest EPS estimate is ($0.10) and the lowest is ($0.11). Motus GI reported earnings of ($0.12) per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 16.7%. The business is scheduled to report its next quarterly earnings report on Tuesday, March 15th.
According to Zacks, analysts expect that Motus GI will report full year earnings of ($0.45) per share for the current year, with EPS estimates ranging from ($0.54) to ($0.36). For the next financial year, analysts forecast that the company will report earnings of ($0.40) per share, with EPS estimates ranging from ($0.43) to ($0.34). Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Motus GI.
Motus GI (NASDAQ:MOTS) last announced its earnings results on Friday, November 12th. The company reported ($0.10) earnings per share for the quarter, meeting the consensus estimate of ($0.10). Motus GI had a negative return on equity of 78.81% and a negative net margin of 5,675.00%. During the same quarter in the prior year, the business posted ($0.13) earnings per share.
Several institutional investors and hedge funds have recently modified their holdings of MOTS. Geode Capital Management LLC raised its holdings in shares of Motus GI by 59.4% in the 2nd quarter. Geode Capital Management LLC now owns 333,925 shares of the company’s stock worth $347,000 after buying an additional 124,458 shares in the last quarter. Virtu Financial LLC acquired a new stake in Motus GI during the 1st quarter valued at $146,000. Millennium Management LLC acquired a new stake in Motus GI during the 1st quarter valued at $104,000. State Street Corp acquired a new stake in Motus GI during the 2nd quarter valued at $83,000. Finally, Squarepoint Ops LLC acquired a new stake in Motus GI during the 1st quarter valued at $68,000. 14.98% of the stock is owned by institutional investors and hedge funds.
NASDAQ:MOTS traded up $0.01 during mid-day trading on Thursday, hitting $0.51. 719,961 shares of the company’s stock traded hands, compared to its average volume of 2,327,935. The firm has a 50 day moving average of $0.65 and a two-hundred day moving average of $0.84. The company has a current ratio of 9.40, a quick ratio of 9.21 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $24.57 million, a price-to-earnings ratio of -0.89 and a beta of 2.43. Motus GI has a 12 month low of $0.46 and a 12 month high of $2.74.
About Motus GI
Motus GI Holdings, Inc is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Recommended Story: What are the benefits of a portfolio tracker?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.